Jeffrey O. Tom, MD, MS

Articles by Jeffrey O. Tom, MD, MS

Improving Adherence to Cardiovascular Disease Medications With Information Technology

ByWilliam M. Vollmer, PhD,Ashli A. Owen-Smith, PhD,Jeffrey O. Tom, MD, MS,Reesa Laws, BS,Diane G. Ditmer, PharmD,David H. Smith, PhD,Amy C. Waterbury, MPH,Jennifer L. Schneider, MPH,Cyndee H. Yonehara, BS,Andrew Williams, PhD,Suma Vupputuri, PhD,Cynthia S. Rand, PhD

November 16th 2014

Improving adherence to long-term medication therapy remains a challenge. Health information technology interventions that leverage electronic medical records are promising, low-cost approaches for increasing adherence.

Well-Child Care Visits and Risk of Ambulatory Care-Sensitive Hospitalizations

ByJeffrey O. Tom, MD, MS,Rita Mangione-Smith, MD, MPH,David C. Grossman, MD, MPH,Cam Solomon, PhD,Chien-Wen Tseng, MD, MPH

May 10th 2013

Timely well-child care visits may play a role in decreasing unnecessary hospitalizations in children in integrated healthcare delivery systems.

Latest Updated Articles

Improving Adherence to Cardiovascular Disease Medications With Information Technology
November 16th 2014
Well-Child Care Visits and Risk of Ambulatory Care-Sensitive Hospitalizations
May 10th 2013

Jeffrey O. Tom, MD, MS

Articles by Jeffrey O. Tom, MD, MS

Improving Adherence to Cardiovascular Disease Medications With Information Technology

Well-Child Care Visits and Risk of Ambulatory Care-Sensitive Hospitalizations

Latest Updated Articles

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD

SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD